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Abstract
Background: Congenital talipes equinovarus (CTEV) is a common developmental disorder of the
foot, affecting between 1 and 4.5 per 1000 live births. The aetiology is not well elucidated. While
both genetic and environmental factors are implicated, no specific genes have been identified and
little is known about environmental risk factors.
Methods: We conducted a case-control study of idiopathic congenital talipes equinovarus (ICTEV)
in the United Kingdom. 194 cases and 60 controls were recruited. Pedigrees were obtained for 167
cases.
Results:  The rank of the index pregnancy, maternal education and caesarean delivery were
significantly associated with ICTEV risk in a multivariate model. There were suggestions that
maternal use of folic acid supplements in the three months before the pregnancy decreased ICTEV
risk, and that parental smoking during the pregnancy increased risk, although the associations were
not statistically significant. One quarter of pedigrees showed a family history of CTEV, and
autosomal dominant inheritance was suggested in some of these.
Conclusion: Uterine restriction did not appear to have a strong influence on ICTEV development
in our study. Large population-based studies are needed to clarify the aetiology of this common
developmental disorder.
Background
Congenital talipes equinovarus (CTEV) is a common
developmental disorder of the foot. It is defined as fixa-
tion of the foot in cavus, adductus, varus and equinus (i.e.
inclined inwards, axially rotated outwards, and pointing
downwards) with concomitant soft tissue abnormalities
[1]. CTEV may be syndromic, when it is associated with
other neuromuscular and neurological disorders, or idio-
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pathic (ICTEV). Severity varies from cases that resolve
with conservative treatment, to rigid, deformed feet
requiring prolonged management and surgery through-
out childhood and early adulthood, with persistent disa-
bility and discomfort into later life. The birth prevalence
of ICTEV is between 1 and 4.5 per 1000 [2]. The mecha-
nism by which ICTEV develops is unknown; mechanical,
neurological, muscular, bony, connective tissue and vas-
cular mechanisms have all been proposed [3]. The aetiol-
ogy is not well elucidated. Whilst both genetic and
environmental factors are implicated, no specific genes
have been identified and little is known about environ-
mental risk factors [4].
The UK Talipes Study was designed to investigate the aeti-
ology and describe patterns of management of ICTEV in
the UK. In this article we report the epidemiological find-
ings and describe pedigree analyses of families affected by
ICTEV.
Methods
Three groups of children with ICTEV, and their parents,
were recruited between 1st July 1993 and 1st July 1997. All
children had been diagnosed with ICTEV by a treating
orthopaedic surgeon. The source of the first series was the
Scottish Talipes Register, which was established in 1993
and included all hospitals involved in CTEV management
[5]. The source of the second series was the North of Eng-
land Talipes Register, which was set up in 1970 in the
Doncaster and Montague Royal Infirmary and included
children treated for CTEV at that hospital. The third series
comprised children whose CTEV had been managed in
Great Ormond Street Hospital for Sick Children, London,
since 1982. Great Ormond Street effectively operated as a
tertiary referral centre for South Eastern England.
Families were approached by letter and invited to partici-
pate by attending their local hospital for orthopaedic
assessment and interview and by completing question-
naires. The orthopaedic assessment comprised notes
review and clinical examination in order to confirm non-
syndromic status. Family history was recorded on a pedi-
gree for each family that attended for interview. Each fam-
ily was approached only once. The questionnaires
included sections on the nature of the ICTEV (laterality,
details of operations, etc), pregnancy and birth of the
affected (index) child, maternal reproductive history,
parental smoking and alcohol use, parental education and
ethnicity. Families were given the option of completing
the questionnaires without attending interview. We
recruited unaffected cousins as controls. These were sex
and age-matched to cases where possible. The question-
naires were sent by the index family to the potential con-
trol family, and returned directly to the investigators.
Analyses were conducted using Stata 8 [6]. We carried out
univariate analysis by computing unmatched odds ratios
(OR) with 95% confidence intervals (CI) for each epide-
miological variable, using logistic regression, adjusting for
the matching variables of year of birth and sex. Analysis of
parental smoking was conducted for all subjects com-
bined and after stratification by the sex of the index child,
since there are reports of sex differences in the literature
[7,8]. The Mann-Whitney non-parametric test was used
for comparison of birth weight. A multivariate regression
model was built that included the matching variables and
any factors for which the likelihood ratio test in the uni-
variate analysis had a p value of <0.1. In addition, for
cases, chi-squared tests were used to explore associations
between the epidemiological variables and the child's sex
and the laterality of the affected foot/feet. From the pedi-
grees, the total number of affected and unaffected 1st and
2nd degree relatives was calculated and the ratio of
affected to total relatives of each degree was calculated.
The study was approved by the Grampian Research Ethics
Committee.
Results
458 ICTEV subjects were eligible for the study and 194
participated by completing the questionnaires (response
rate 42%); 167 also attended for interview. Cousin con-
trols were recruited for 60 (31%) participants. The charac-
teristics of the cases and controls are summarized in Table
1. Participants and non-participants from the Scottish Tal-
ipes Register were compared in terms of sex, laterality and
period of birth and there were no significant differences
(data not shown).
The ratio of males to females was 2.1:1. Fifty one percent
had bilateral ICTEV (48% of males; 55% of females). Of
the unilateral cases, more had right foot involvement than
left (57% right; 43% left). Females who were affected uni-
laterally were more than twice as likely to be affected on
the right than the left, whereas in males left and right sides
were equally affected (females 29% left, 71% right; males
48% left, 52% right); the differences were not statistically
significant. Three quarters of cases were born in 1990 or
later.
There were ten twin pregnancies amongst the cases (5%),
nine of which were reported to be non-identical; the
zygosity was unknown for the tenth. None of the non-
index twins had CTEV. There were no multiple pregnan-
cies amongst controls. Eighty one percent of ICTEV deliv-
eries were vaginal with cephalic presentation, 2% were
vaginal with breech presentation and 17% were caesarean.
In controls, the corresponding figures were 93%, 2% and
5%. Odds ratios, adjusted for sex and year of birth, were
significantly raised for caesarean section (Table 1). TheBMC Musculoskeletal Disorders 2007, 8:62 http://www.biomedcentral.com/1471-2474/8/62
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Table 1: Characteristics of cases and controls
Characteristic Case1 Control1
n (%) n (%) p OR2 (95% CI)
Sex of index child3 male 130 (67.0) 38 (63.3) - 1.0 (ref)
female 64 (33.0) 22 (36.7) 0.60 0.47 (0.47–1.56)
Affected foot male left 26 (25.0) - - - - -
right 28 (26.9) - - - - -
both 50 (48.1) - - - - -
Affected foot female left 6 (12.8) - - - - -
right 15 (31.9) - - - - -
both 26 (55.3) - - - - -
Year of birth 1963–1979 14 (7.2) 4 (6.7) -
1980–1989 32 (16.5) 15 (25.0) -
1990–1994 61 (31.4) 25 (41.7) -
1995–1999 87 (44.8) 16 (26.7) -
Multiple pregnancy yes 10 (5.1) 0 (0.0) 0.07 3.244 -
no 185 (94.9) 60 (100)
Type of delivery Cephalic 157 (80.7) 56 (93.3) - 1.00 (ref)
Breech 4 (2.1) 1 (1.7) 0.71 1.52 (0.16–14.19)
Caesarean 33 (17.2) 3 (5.0) 0.04 3.71 (1.09–12.62)
Birth weight mean 3622 g 3397 g 0.105 -
range 1247–4564 g 1531–4508 g - - -
Stillbirth6 5 (2.6) 1 (1.7) 1.77 (0.20–15.81)
Miscarriage6 50 (25.8) 15 (25.4) 1.04 (0.53–2.03)
Abortion6 33 (17.2) 9 (15) 1.14 (0.51–2.56)
Age of mother at birth of index child ≤19 8 (4.2) 1 (1.7) 0.25 3.56 (0.41–31.06)
20–24 39 (20.2) 12 (20.0) 0.53 1.25 (0.55–2.83)
25–29 64 (33.2) 23 (38.3) - 1.00 (ref)
30–34 53 (27.5) 16 (26.7) 0.74 1.14 (0.54–2.39)
35–39 23 (11.9) 7 (11.7) 0.79 1.14 (0.43–3.03)
≥40 6 (3.1) 1 (1.7) 0.48 2.19 (0.25–19.35)
Age of father at birth of index child ≤19 2 (1.1) 1 (2.3) 0.62 0.53 (0.05–6.27)
20–24 20 (11.4) 5 (11.4) 0.87 1.10 (0.36–3.40)
25–29 43 (24.4) 7 (15.9) 0.34 1.16 (0.61–4.21)
30–34 63 (35.8) 17 (38.6) - 1.00 (ref)
35–39 31 (17.6) 10 (22.7) 0.60 0.78 (0.31–1.94)
≥40 17 (9.7) 4 (9.1) 0.82 1.15 (0.34–3.91)
Rank of index pregnancy 1 81 (41.8) 32 (53.3) - 1.00 (ref)
2 66 (34.0) 22 (36.7) 0.61 1.18 (0.63–2.23)
3 27 (13.9) 4 (6.7) 0.10 2.60 (0.84–8.05)
4+ 20 (10.3) 2 (3.3) 0.09 3.67 (0.81–16.74)
Total gravidity of mother 1 36 (18.5) 8 (13.3) - 1.00 (ref)
2 68 (34.9) 29 (48.3) 0.20 0.56 (0.23–1.35)
3 48 (24.6) 13 (21.7) 0.72 0.83 (0.31–2.23)
4+ 43 (22.1) 10 (16.7) 0.90 1.07 (0.37–3.05)
Total parity of mother 1 52 (26.8) 14 (23.3) - 1.00 (ref)
2 83 (42.8) 33 (55.0) 0.35 0.71 (0.34–1.45)
3 38 (19.6) 10 (16.7) 0.88 1.08 (0.43–2.71)
4+ 21 (10.8) 3 (5.0) 0.28 2.15 (0.54–8.47)
Maternal use of folic acid in 3 months before or during first trimester of 
pregnancy with index child
no 144 (74.2) 46 (76.7) - 1.00 (ref)
yes 50 (25.8) 14 (23.3) 0.67 0.86 (0.43–1.73)
Maternal smoking during pregnancy with index child no 129 (66.5) 44 (73.3) - 1.00 (ref)
yes 65 (33.5) 16 (26.7) 0.34 1.37 (0.72–2.62)
Paternal smoking during pregnancy with index child no 101 (58.7) 30 (66.7) - 1.00 (ref)
yes 71 (41.3) 15 (33.3) 0.29 1.46 (0.72–2.95)
Maternal alcohol consumption during pregnancy with index child no 127 (65.5) 34 (56.7) - 1.00 (ref)
yes 67 (34.5) 26 (43.3) 0.21 0.69 (0.38–1.24)
Maternal education or training beyond secondary school no 70 (37.6) 30 (52.6) - 1.00 (ref)
yes 116 (62.4) 27 (47.4) 0.09 1.71 (0.93–3.16)
Paternal education or training beyond secondary school no 52 (31.3) 12 (27.3) - 1.00 (ref)
yes 114 (68.7) 32 (72.7) 0.48 0.76 (0.35–1.62)
1 Denominator varies according to available data
2 Adjusted for year of birth and sex of index child
3 Index child is the child with ICTEV, or cousin control
4 χ2 test
5 Mann-Whitney U test
6 At some time in the reproductive history of the motherBMC Musculoskeletal Disorders 2007, 8:62 http://www.biomedcentral.com/1471-2474/8/62
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increased risk associated with caesarean section was not
accounted for by maternal age nor the rank of the index
pregnancy, as inclusion of these variables in the model
had little impact on the risk estimate. The association per-
sisted when the analysis was restricted to singletons (age
and sex adjusted OR 3.01, 95% CI 0.87–10.38), and in the
final multivariate model (see below). The mean birth
weight of cases was greater than that of controls (3622 g
and 3397 g respectively), but the difference was not statis-
tically significant.
At some time in her reproductive history, 26% (50/192)
of case and 25% (15/59) of control mothers had had at
least one miscarriage; 3% (5/191) of case and 2% (1/60)
of control mothers had had a stillbirth and 17% (33/192)
of case and 15% (9/60) of control mothers had had at
least one abortion.
The median age of mothers at the birth of the index child
was 28 years for both cases and controls (case range 15–
43, control range 18–40). The median age of fathers was
31 years for cases (range 17–58) and 30 years for controls
(range 19–50). The median age of the mother at the birth
of her first child was 24 years for cases (range 15–38) and
25 years for controls (range 16–38).
The index pregnancy was the first for 42% of case and
53% of control mothers. The risk of ICTEV increased sig-
nificantly with the rank of the pregnancy (p for trend =
0.03). Adjusting for maternal age made minimal differ-
ence to the risk estimates. Further adjustment in the final
multivariate model (see below) increased the risk esti-
mates slightly. The mean parity was 2.2 for case (range 1–
6) and 2.1 for control (range 1–6) mothers.
Around one quarter of mothers (26% cases; 23% con-
trols) reported using nutritional supplements containing
folic acid in the three months before the index pregnancy
or in the first trimester. Use increased with the year of
birth of the child and was 5% for births 1963–1979, 13%
for 1980–1989, 23% for 1990–1994 and 28% for 1995–
1999. The increase over time was statistically significant
(p for trend <0.001). Use of these supplements was asso-
ciated with a modest, but non-significant, reduced risk of
ICTEV. When the analysis was restricted to folic acid taken
in the three months prior to the pregnancy the effect was
more pronounced (OR 0.55, 95% CI 0.23–1.29), but
remained non-significant.
More case than control parents reported smoking during
the index pregnancy (mothers: 34% cases, 27% controls;
fathers: 41% cases, 33% controls); the differences were
not significant. Whilst the association with maternal
smoking was stronger in female than male children (male
OR 1.16 [95% CI 0.53–2.55]; female OR 2.28 [95% CI
0.68–7.66]), the risk estimates were not statistically signif-
icant, nor was a formal test of interaction between sex and
maternal smoking significant (p = 0.41). Fewer case than
control mothers reported drinking alcohol during the
index pregnancy (35% cases, 43% controls), but the dif-
ferences were not significant.
More case than control mothers had further education or
training (cases 62% [116/186]; controls 47% [27/57]),
although the difference was not statistically significant.
Fathers of cases and controls had similar levels of further
education.
Table 2 shows the results of multivariate modeling, with
mutually adjusted odds ratios and 95% confidence inter-
vals. The final model included the matching variables (sex
and year of birth), rank of the index pregnancy (1, 2, 3,
4+), type of birth (normal, breech, caesarean), and
mother's further education or training (any/none). The
model could not be fitted with twin status, as there were
no twins amongst controls. There was a statistically signif-
icant trend of increasing risk with increasing pregnancy
rank. Mothers for whom the index pregnancy was at least
the fourth had over three and a half times the risk of an
ICTEV child than a mother for whom the pregnancy was
the first. There was a four-fold risk associated with caesar-
ean compared with normal vaginal delivery. Risk of an
ICTEV birth was increased by 75% among mothers with
further education, although the risk estimate was not sta-
tistically significant. Risk estimates for models that
included and excluded twins were similar.
In the case-only analysis there were no statistically signif-
icant associations between sex and laterality (unilateral/
bilateral), nor between the sex of the case and multiple
birth, type of birth, rank of the pregnancy, parental smok-
ing, maternal alcohol use or maternal education. In addi-
tion, there were no associations between these variables
and laterality (right only, left only, bilateral). For maternal
use of folic acid, there were significantly fewer females
than expected in the group whose mothers used supple-
ments (χ2
1 7.53, p = 0.01) but the test for interaction
between sex and folic acid use was not significant (p =
0.18). Folic acid use was not associated with laterality.
A pedigree was available for 167 families. Families with
and without pedigrees were compared for the variables in
Table 1; there were no significant differences (data not
shown). The sex ratio of the cases for whom a pedigree
was obtained was 1.98:1 (111 [66.5%] male; 56 [33.5%]
female), very similar to the main study. Almost one quar-
ter (40/167, 24%) of families reported a family history of
CTEV; 16.2% (27/167) had a 1st–3rd degree family history,
7.8% (13/167) a 1st degree family history and 4.2% (7/
167) a 2nd degree family history; 10.8% (18/167) had aBMC Musculoskeletal Disorders 2007, 8:62 http://www.biomedcentral.com/1471-2474/8/62
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1st or 2nd degree family history, and 1.2% (n = 2) a 1st and
2nd degree family history. Of the 13 families with a 1st
degree family history, there were six child-parent pairs, six
sib-pairs and one trio in which both a parent and a sib
were affected. Six families had three or more cases of CTEV
in the family (3.6%); the pedigrees of three of these sug-
gested autosomal dominant inheritance whilst the mode
of inheritance was uncertain in the remainder.
Male index cases were more likely to have a family history
than female index cases; 18.9% of males (n = 20) and
12.5% of females (n = 7) had a 1st–3rd degree family his-
tory. Eight percent of males (n = 9) and 7.1% of females
(n = 4) had a 1st degree family history, and 5.4% of males
(n = 6) and 1.8% of females (n = 1) had a 2nd degree fam-
ily history. None of these differences reached statistical
significance (data not shown).
Of the 167 index cases, 2.7% of 1st degree relatives (14/
528; 95% CI 1.46–4.41) and 0.5% of 2nd degree relatives
(7/1473; 95% CI 0.19–0.98) were reported to have CTEV.
The absolute risk of any 1st or 2nd degree relative being
affected was 1.1% (21/2001; 95% CI 0.65–1.60). Slightly
more relatives of male (1.2%, 16/1341; 95% CI 0.68–
1.93) than female (0.8%, 5/660; 95% CI 0.25–1.76)
index cases had ICTEV. The risk to each male relative,
regardless of the sex of the case, was 1.2% (12/1017; 95%
CI 0.61–2.05) and for each female relative was 0.9% (9/
984; 95% CI 0.42–1.73). When the case was male the risk
of CTEV was higher for male (1.5%, 10/675; 95% CI
0.71–2.71) than female (0.9%; 6/666; 95% CI 0.33–1.95)
relatives. When the index case was female the risk of CTEV
was slightly higher for female relatives (risk to males
0.6%; 2/342; 95% CI 0.07–2.10; risk to females 0.9%, 3/
318; 95% CI 0.19–2.73). None of these differences
reached statistical significance (data not shown).
Cross-tabulations between 1st–3rd degree family history
and the variables sex, laterality, maternal alcohol and
maternal smoking showed no associations. There was a
significant association between family history and pater-
nal smoking (χ2
1 = 4.61, p = 0.03), but not with maternal
smoking (χ2
1 = 0.51, p = 0.48).
Discussion
The sex ratio in our study and the predominance of bilat-
eral disease mirrors the pattern seen in other studies of
children with ICTEV [9-19]. Of the unilateral cases, the
slight predominance of right over left-sided ICTEV is in
line with most reported series [2,10,12,16,19]. This,
together with comparison of participants and non-partic-
ipants of the Scottish part of the study, suggests that our
series is not severely biased and that our results are likely
to be generalisable, despite the relatively low participation
rate.
Five percent of cases but no controls were twin births. The
rate of twinning in our cases was significantly higher than
the Scottish rate for 1996–2000 of 1.4% [20] (χ2 19.99,
p<0.001). If this rate held amongst controls, we would
have expected one twin birth. Uterine restriction is the
earliest known hypothesis proposed to account for CTEV,
with references dating back to Hippocrates in the 5th cen-
tury BC. Our finding of a higher twin birth rate in cases
than controls could be considered to support this hypoth-
esis. However, we also found a positive association
between risk of ICTEV and the rank of the index preg-
nancy; if it is assumed that the primagravid uterus is more
restrictive than a multigravid uterus, uterine restriction is
not a major factor in our series.
The rate of caesarean delivery was significantly higher in
our cases than controls (17% vs. 5%). We did not have
information on why the caesareans were performed. Twin
births accounted for some of the excess, as 6/10 twin
births were delivered by caesarean section, but the associ-
ation remained when the analysis was restricted to single-
tons. The frequency of caesarean deliveries for singleton
ICTEV pregnancies in our study (14%) is consistent with
figures for the Scottish population, taking into account
Table 2: Final regression model from the case-control analysis
Risk factor p OR1 (95% CI)
Rank of index pregnancy 1 ref 1.00 (ref)
2 0.38 1.35 (0.69–2.65)
3 0.08 2.81 (0.87–9.03)
4+ 0.12 3.49 (0.73–16.80)
p for trend 0.03
Type of birth Normal ref 1.00 (ref)
Breech 0.61 1.83 (0.19–18.13)
Caesarean 0.02 5.55 (1.27–24.27)
Maternal further education None ref 1.00 (ref)
Some 0.07 1.80 (0.95–3.40)
1 Adjusted for year of birth and sex of index childBMC Musculoskeletal Disorders 2007, 8:62 http://www.biomedcentral.com/1471-2474/8/62
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the range of years of birth covered by our study [21]. Thus
the observed association may be due to the lower than
expected frequency of caesarean births among controls.
Maternal education and birth rank were also significant in
our final model, both being positively associated with the
risk of ICTEV. Maternal education, which may be seen as
an indicator of socioeconomic status, has been infre-
quently reported and findings are inconsistent with posi-
tive [7], inverse [19] and no association [18] reported. The
studies vary in their categorisation of 'further education'.
If our study participants were biased in terms of education
we might expect mothers of controls to have higher edu-
cation than mothers of cases, and this was not the case.
We found a positive association between risk of CTEV and
parity, in contrast to the findings of Moorthi et al (2005)
[19]. Birth rank and parity have not generally been found
to be associated with ICTEV risk [7,8,10,18,22]. The asso-
ciations between maternal education and birth rank and
risk of CTEV require further investigation in other studies.
Folate appears to play a role in some congenital malfor-
mations, particularly neural tube defects [23]. An associa-
tion has been reported between CTEV and higher levels of
maternal plasma homocysteine, which is inversely related
to plasma folate [24,25]. Approximately one quarter of
mothers in our study reported peri-conceptional use of
folic acid. Maternal use of supplements containing folic
acid in the three months before the index pregnancy, or in
the first trimester, was associated with a modestly reduced
risk of ICTEV, although this was not statistically signifi-
cant. The effect was most pronounced for use in the period
immediately before the pregnancy (OR 0.55, 95% CI
0.23–1.29). Rotation of the foot into the plantar (sole on
the ground) position commences between nine and 13
weeks, and continues throughout gestation [26]. The asso-
ciation with folic acid supplement use may be a chance
finding, or may suggest that the initiation of ICTEV is ear-
lier than previously thought. That folic acid may play a
role in the development of CTEV is also indicated by a
small decrease in the birth prevalence of ICTEV in Texas,
United States, after the introduction of folic acid fortifica-
tion of grains, although the decrease was not statistically
significant [19]. Further, a United Kingdom case-parent
triad study has demonstrated an association between the
risk of ICTEV and the C677T polymorphism in the meth-
ylenetetrahydrofolate reductase gene, a gene that is
involved in folate metabolism [27]. Further investigation
of these intriguing results is warranted, particularly in
view of the potential implications for public health policy
on peri-conceptional folic acid supplementation.
Maternal smoking has been implicated as a risk factor for
CTEV [7,28-30]. In line with this, we found that more case
than control mothers smoked during pregnancy (34% vs.
27%), although the difference was not statistically signifi-
cant. The prevalence of maternal smoking in our study is
consistent with Scottish survey data for 1993–1997 [31].
Skelly et al 2002 [7] observed a stronger effect of maternal
smoking in girls than boys, and our data also suggested
this pattern; however Alderman et al (1991) report a
stronger effect in boys [8]. Honein et al (2000) demon-
strated an interaction between maternal smoking and
family history of ICTEV, with an odds ratio of 20.30
(7.90–51.17) for the combination of maternal smoking
and family history [30]. We found a significant associa-
tion between family history and paternal smoking, but
not with maternal smoking. If family history is considered
a marker of genetic involvement, this relationship may
indicate an interaction between smoking and an as-yet
unknown gene or genes, although it is unclear why the
relationship should be with paternal rather than maternal
smoking.
One quarter of children had a family history of CTEV,
which corresponds with the upper limit of the estimates
reported in two series in the USA [16,32], but is slightly
lower than the estimate from a series of 120 children from
Glasgow [12]. The families from whom we obtained a
pedigree did not differ from those from whom we did not
in terms of the variables in Table 1. We restricted our anal-
ysis of risk of CTEV to family members to 1st–2nd degree
relatives as this was considered the most reliable data.
The proportion of CTEV families reported to have a 1st
degree family history differs widely. Our frequency of
7.8% is similar to that of 7.2% reported by Honein et al
[30], whilst Skelly et al (2002) report 9.2% [7], Cartlidge
(1984) 12.5% [12] and Wynne-Davies (1972) 21.4%
[33]. The absolute risk of CTEV in 1st degree relatives in
our study was 2.7%, within the range reported in the liter-
ature (2.1–3.6%) [10,16,30,33].
We found an increased risk of a family history of CTEV in
male compared with female index cases, although the dif-
ference was not statistically significant. The highest risk of
CTEV in our study was in male relatives of male probands,
contrary to Wynne-Davis (1964) who found the highest
risk in male relatives of female probands in a series of 635
UK cases [34]. We had insufficient affected families to per-
form a formal segregation analysis.
The heterogeneity between studies in reported risk factors
for CTEV may be due to many factors including defini-
tions of CTEV, whether non-idiopathic cases are included,
differences in study design, and chance as some series are
relatively small. Participation bias may also play a role,
possibly with multi-case families or those with more
severely affected children more likely to take part. Studies
of family history of CTEV are likely to vary in the degree ofBMC Musculoskeletal Disorders 2007, 8:62 http://www.biomedcentral.com/1471-2474/8/62
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evidence considered sufficient for a 'diagnosis' of CTEV in
relatives. The aetiology of CTEV is undoubtedly complex
and it is probable that both environmental and genetic
factors are involved. The genetic influence itself is likely to
be complex and may involve multiple genes or genetic
pathways, themselves interacting with environmental fac-
tors.
Conclusion
We have given an epidemiological picture of a large series
of children with ICTEV in the UK. Autosomal dominant
inheritance seems to be present in some of the families,
although the mode of inheritance was unclear for the
majority of multi-case families. Cesarean delivery, birth
rank and maternal education were all significantly associ-
ated with the risk of ICTEV. Uterine restriction does not
seem to play a major role in our series. We found signifi-
cant associations between family history and paternal
smoking, which may indicate an interaction between
smoking and an as-yet unknown gene or genes. Studies of
unbiased series from different geographical and ethnic
groups are essential for elucidating both the genetic and
epidemiological factors involved in the aetiology of this
common development disorder.
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